Radjesh J Bisoendial Selected Research

Hypoalphalipoproteinemias (Hypoalphalipoproteinemia)

12/2009	Reduced fecal sterol excretion in subjects with familial hypoalphalipoproteinemia.
9/2005	Consequences of cholesteryl ester transfer protein inhibition in patients with familial hypoalphalipoproteinemia.
6/2003	Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein.
6/2003	The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Radjesh J Bisoendial Research Topics

Disease

4	Inflammation (Inflammations) 01/2022 - 04/2005
4	Hypoalphalipoproteinemias (Hypoalphalipoproteinemia) 12/2009 - 06/2003
3	Rheumatoid Arthritis 01/2022 - 03/2010
3	Atherosclerosis 09/2010 - 04/2005
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2010 - 03/2010
2	Type 2 Diabetes Mellitus (MODY) 10/2014 - 11/2007
1	Joint Diseases (Joint Disease) 08/2022
1	Pain (Aches) 01/2022
1	Psoriatic Arthritis 01/2020
1	Synovitis 01/2020
1	Infections 01/2019
1	Neointima 01/2015
1	Pathologic Constriction (Stenosis) 01/2015
1	Stroke (Strokes) 02/2012
1	Myocardial Infarction 02/2012
1	Abdominal Aortic Aneurysm 02/2012
1	Communicable Diseases (Infectious Diseases) 06/2009
1	Hypercholesterolemia 04/2007
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2004

Drug/Important Bio-Agent (IBA)

5	C-Reactive ProteinIBA 01/2019 - 04/2005
3	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2015 - 10/2004
2	Adenosine Triphosphate (ATP)IBA 06/2003 - 06/2003
1	Adalimumab (Humira)FDA Link 08/2022
1	Biosimilar PharmaceuticalsIBA 08/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	CytokinesIBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2019
1	FibrinIBA 01/2015
1	ApolipoproteinsIBA 10/2014
1	HDL LipoproteinsIBA 10/2014
1	LipidsIBA 07/2013
1	Interleukin-6 (Interleukin 6)IBA 07/2013
1	LDL Receptors (LDL Receptor)IBA 07/2013
1	tocilizumab (atlizumab)FDA Link 07/2013
1	Lipoproteins (Lipoprotein)IBA 07/2013
1	Proteins (Proteins, Gene)FDA Link 02/2012
1	5-Lipoxygenase-Activating ProteinsIBA 02/2012
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 02/2012
1	LeukotrienesIBA 02/2012
1	Indicators and Reagents (Reagents)IBA 09/2010
1	Inflammation MediatorsIBA 06/2010
1	LDL CholesterolIBA 03/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2010
1	SterolsIBA 12/2009
1	Glucose (Dextrose)FDA LinkGeneric 11/2007
1	oxidized low density lipoproteinIBA 04/2007
1	Cholesterol Ester Transfer ProteinsIBA 09/2005
1	CholesterolIBA 06/2003
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 06/2003

Therapy/Procedure

1	Synovectomy 01/2022
1	Stents 01/2015
1	Glycemic Control 10/2014